C. Weber-Schoendorfer

发表

Pregnancy outcome after paternal exposure to azathioprine/6-mercaptopurine.

A. Allignol, M. Hoeltzenbein, C. Weber-Schoendorfer, 2012, Reproductive toxicology.

Pregnancy outcome after tocilizumab therapy in early pregnancy-a case series from the German Embryotox Pharmacovigilance Center.

C. Weber-Schoendorfer, C. Schaefer, C. Weber‐Schoendorfer, 2016, Reproductive toxicology.

Atypical Antipsychotic Drugs and Pregnancy Outcome: A Prospective, Cohort Study

A. Allignol, C. Weber-Schoendorfer, R. Meister, 2013, Journal of clinical psychopharmacology.

Pregnancy outcome after first trimester exposure to bisoprolol: an observational cohort study

M. Hoeltzenbein, C. Weber-Schoendorfer, R. Meister, 2018, Journal of hypertension.

Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services

M. Clementi, A. Allignol, É. Élefant, 2012, American journal of medical genetics. Part A.

Increased rate of birth defects after first trimester use of angiotensin converting enzyme inhibitors - Treatment or hypertension related? An observational cohort study.

M. Hoeltzenbein, C. Weber-Schoendorfer, R. Meister, 2018, Pregnancy hypertension.

Handle with care — interpretation, synthesis and dissemination of data on paracetamol in pregnancy

P. Damkier, C. Weber-Schoendorfer, A. Panchaud, 2021, Nature Reviews Endocrinology.

Leflunomide - A human teratogen? A still not answered question. An evaluation of the German Embryotox pharmacovigilance database.

C. Weber-Schoendorfer, C. Schaefer, E. Beck, 2017, Reproductive toxicology.

Infliximab and adalimumab use during breastfeeding.

C. Weber-Schoendorfer, C. Schaefer, D. Mury, 2012, Journal of clinical gastroenterology.

Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series

J. Sobesky, C. Weber-Schoendorfer, C. Schaefer, 2013, European journal of neurology.

Pregnancy Outcome After Methotrexate Treatment for Rheumatic Disease Prior to or During Early Pregnancy: A Prospective Multicenter Cohort Study

G. Koren, C. Chambers, M. Clementi, 2014, Arthritis & rheumatology.

Methotrexate in pregnancy: still many unanswered questions

C. Weber-Schoendorfer, O. Diav-Citrin, 2023, RMD Open.

Angiotensin-II receptor 1 antagonist fetopathy--risk assessment, critical time period and vena cava thrombosis as a possible new feature.

C. Weber-Schoendorfer, C. Schaefer, S. Padberg, 2013, British Journal of Clinical Pharmacology.

Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.

M. Clementi, A. Ornoy, C. Weber-Schoendorfer, 2008, British journal of clinical pharmacology.

Neonatal effects of intrauterine metoprolol/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groups.

M. Hoeltzenbein, C. Weber-Schoendorfer, R. Meister, 2020, Journal of hypertension.

No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study.

M. Hoeltzenbein, C. Weber-Schoendorfer, R. Meister, 2014, Rheumatology.

Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy

C. Weber-Schoendorfer, R. Meister, C. Schaefer, 2010, Archives of Gynecology and Obstetrics.

Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study.

D. Kennedy, D. Beghin, C. Weber-Schoendorfer, 2015, British journal of clinical pharmacology.

Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome

C. Weber-Schoendorfer, R. Meister, C. Schaefer, 2015, Pharmacoepidemiology and drug safety.

Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerations.

M. Clementi, A. Ornoy, C. Weber-Schoendorfer, 2008, Reproductive toxicology.

The Outcomes of Pregnancy in Women Exposed to the New Macrolides in the First Trimester

M. Clementi, M. Berkovitch, B. Stahl, 2012, Drug Safety.

A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy.

A. Allignol, C. Weber-Schoendorfer, R. Meister, 2012, Vaccine.

Pregnancy Outcome After First Trimester Use of Methyldopa: A Prospective Cohort Study

M. Hoeltzenbein, C. Weber-Schoendorfer, R. Meister, 2017, Hypertension.

Pregnancy outcome following first-trimester exposure to fingolimod: A collaborative ENTIS study

V. Rousson, V. Rollason, T. Buclin, 2020, Multiple sclerosis.

The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.

Reinhard Meister, Thierry Vial, Christof Schaefer, 2008, Reproductive toxicology.

Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: an observational study.

B. te Winkel, M. Hoeltzenbein, C. Weber-Schoendorfer, 2019, Journal of hypertension.

The safety of cetirizine during pregnancy. A prospective observational cohort study.

Christof Schaefer, C. Weber-Schoendorfer, C. Schaefer, 2008, Reproductive toxicology.

Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study

C. Weber-Schoendorfer, C. Schaefer, C. Weber‐Schoendorfer, 2009, Multiple sclerosis.

Reversible oligohydramnios in the second trimester of pregnancy in two patients with long-term diclofenac exposure.

C. Weber-Schoendorfer, C. Schaefer, S. Scherneck, 2015, Reproductive toxicology.

Pregnancy outcome after first-trimester exposure to metformin: A prospective cohort study.

C. Weber-Schoendorfer, C. Schaefer, S. Scherneck, 2018, Reproductive toxicology.

Pregnancy outcome after first trimester use of angiotensin AT1 receptor blockers: an observational cohort study

M. Hoeltzenbein, C. Weber-Schoendorfer, R. Meister, 2018, Clinical Research in Cardiology.

Observational Cohort Study of Pregnancy Outcome after First-Trimester Exposure to Fluoroquinolones

C. Weber-Schoendorfer, R. Meister, C. Schaefer, 2014, Antimicrobial Agents and Chemotherapy.

Fetal outcome after technetium scintigraphy in early pregnancy.

C. Weber-Schoendorfer, R. Meister, C. Schaefer, 2009, Reproductive toxicology.

Ondansetron in pregnancy revisited: Assessment and pregnancy labelling by the European Medicines Agency (EMA) & Pharmacovigilance Risk Assessment Committee (PRAC)

P. Damkier, C. Weber-Schoendorfer, Y. Kaplan, 2020, Basic & clinical pharmacology & toxicology.

Paternal exposure to azathioprine/6-mercaptopurine—Experience of Berlin TIS

M. Hoeltzenbein, C. Weber-Schoendorfer, Cornelia Borisch, 2010 .

Maternal exposure to mycophenolate mofetil in pregnancy—Results of the ENTIS collaborative study

A. Ornoy, P. Merlob, É. Élefant, 2010 .

Paternal exposure to drugs—Is there an increased risk for congenital abnormalities?: Experience of the Berlin Institute for Clinical Teratology and Drug Risk Assessment during Pregnancy

M. Hoeltzenbein, C. Weber-Schoendorfer, C. Schaefer, 2008 .

Trastuzumb exposure during pregnancy.

C. Weber-Schoendorfer, C. Schaefer, 2008, Reproductive Toxicology.

Monoclonal antibody therapy during pregnancy—Experience of the Berlin teratology information service

C. Weber-Schoendorfer, C. Schaefer, 2008 .

2009 H1N1 vaccination in pregnancy—Experience of the European network of teratology information services (ENTIS)

C. Weber-Schoendorfer, R. Meister, C. Schaefer, 2010 .

Birth defect classification for studies of Teratology Information Services

C. Weber-Schoendorfer, C. Schaefer, 2015 .

Fetal outcome after technetium scintigraphy in early pregnancy.

C. Weber-Schoendorfer, R. Meister, C. Schaefer, 2009, Reproductive toxicology.

Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series

C. Weber-Schoendorfer, M. Dostál, Jan Sobesky, 2013, European journal of neurology.